로그인
회원가입
장바구니(
0
)
견적의뢰
ENGLISH
Products
FutureChem Chemicals
PET/SPECT Products
Metal Chelating Agent
Peptides
Chemicals
Disposable Ware
PSMA
API - Active Pharmaceutical Ingredient
Mebrofenin
Precursor (GMP grade)
Linkers (bioconjugation)
Cu-Free Click Linkers
Homobifunctional Linkers
Heterobifunctional Linkers
Linkers with Protecting Groups
Biotinylation Reagents
PEGylation Reagents
Alkanthiols for Self-Assembled Monolayers
Phospholipid PEG Linkers
Hyhobic Linkers
Fluorescence Probe
MTTI Products
Ionic Liquids
Imidazolium-based ionic liquids
Quarternary Ammonium Salts
Piperidinium-based ionic liquids
Pyridinium-based ionic liquids
Pyrrolidinium-based ionic liquids
Ammonium-Based Ionic Liquids
Phosphonium-based ionic liquids
Sulfonium-based ionic liquids
DABCO-Based ionic liquids
Speciality for Ionic Liquids
Ionic liquids Screening Kits
Amino acids & Reagent for Peptide
N-Protecting Reagents
Peptide Coupling Reagents
Linkers for Solid Phase Synthesis
Other Reagents
Amino Acids and Derivatives
Unusual Amino Acids
N-Methyl Amino Acids
Boc-Amino Acids and Derivatives
Fmoc-Amino Acids and Derivatives
Pseudoproline Dipeptides
Z-Amino Acids and Derivatives
Amino Alcohols
Fmoc-Amino Acids Attached to Wang Resin
Amino Acids 2-Chlorotrityl Resin
Other Resin and Derivatives
Custom Synthesis Service
Order
Order center
주문&배송현황
견적의뢰
Support
Download Catalog
Download Documents
Help
공지사항/News
How to Order
FAQ
Contact Us
Sitemap
Help
공지사항/News
공지사항/News
How to Order
FAQ
Contact Us
Sitemap
공지사항/News
퓨쳐켐, 유럽서 FC705 국내 임상 2상 중간 결과 구두발표 예정
Futurechem(future0340) | 2024-09-30 오후 4:32:31 | 조회 212
첨부
▲ 이전글
퓨쳐켐, 혹한기에 130억 투자 ...
2024-09-30<
▼ 다음글
퓨쳐켐, 전립선 암 치료제 'FC...
2024-09-30